Announcements Trials

Browse Landscape

Phase

Status

Unknown 26 Completed 26 Recruiting 21 Not yet recruiting 16 Terminated 6 Active not recruiting 3 Withdrawn 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 370 Neoplasms 253 Carcinoma, Non-Small-Cell Lung 224 Prostatic Neoplasms 192 Lung Neoplasms 142 Colorectal Neoplasms 139 Neoplasm Metastasis 132 Pancreatic Neoplasms 131 Leukemia, Myeloid, Acute 126 Multiple Myeloma 123 Lymphoma 115 Carcinoma, Hepatocellular 111 Ovarian Neoplasms 98 Melanoma 97 Recurrence 93 Leukemia 89 Head and Neck Neoplasms 89 Leukemia, Lymphocytic, Chronic, B-Cell 86 Brain Neoplasms 86 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Glioblastoma 77 Lymphoma, Non-Hodgkin 73 Squamous Cell Carcinoma of Head and Neck 71 Lymphoma, Follicular 70 Lymphoma, Large B-Cell, Diffuse 66 Colonic Neoplasms 66 Carcinoma, Renal Cell 62 Hematologic Neoplasms 59 Sarcoma 55 Glioma 53

Interventions

eribulin 1 balixafortide 1 Taxes 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interventional × Advanced Breast Cancer × Clear all

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡